THE ALLIANCE | How pharma companies & physicians joined forces

Overview | Urology | Dermatology | Hair transplant surgery | Endocrinology | Merck & GSK | Study groups | References | People index

Dermatology


Elise Olsen, MD
Professor of Dermatology and of Medicine, Duke University School of Medicine (profile)


Vera Price, MD
Department of Dermatology, University of California, San Francisco


Janet Roberts, MD
Northwest Cutaneous Research Specialists, Portland, OR; Oregon Health and Science University


Jerry Shapiro, MD
Department of Dermatology, University of British Columbia & Vancouver General Hospital; later moved to NYU Langone Medical Center

  • Finasteride Male Pattern Hair Loss Study Group
    • Investigator, Study 089
  • Consultant and speaker for Merck (disclosed in Fertig et al, 2017)
  • Co-authors: Gormley, Kaufman, Round, Stoner, Olsen, Price, Roberts, Stough, Tosti, Washenik, Whiting
  • Papers
    • Kaufman 1998
    • Shapiro 1998
    • Shapiro 2003
    • Olsen 2005
    • Fertig 2017 – Investigation of the plausibility of 5-alpha-reductase inhibitor syndrome
    • Young 2023 – Focused on telehealth company Keeps where Dr. Shapiro is an Advisor. Co-authored with a Keeps medical officer, an executive of parent company Thirty Madison, and Dr. Antonella Tosti (details below).
  • Engagements with industry*
    • Highlighted: Since mid-2020, Advisor to Thirty Madison, owner of telehealth company Keeps (Advisor profile) (along with Dr. Antontella Tosti). Former investigator, consultant and speaker for Merck’s launch of Propecia.
    • Other engagements with: Aclaris Therapeutics (c), Applied Biology, Bayer (c), DS Laboratories, Eirion, Incyte (c), Johnson & Johnson (c), Kythera (c), L’Oreal Paris (c), Eli Lilly, Pfizer, RegenLab (pi), RepliCel Life Sciences (c,cf,st), Samumed (c).
  • Publishing: Up to Date (author)
  • Editorial roles: Regional Editor, International Journal of Trichology. Member, Editorial Board of Skin Appendage Disorders.
  • Board positions: National Alopecia Areata Foundation (Scientific Board Member), Cicatricial Alopecia Research Foundation (Board of Directors)

* Key: a, author; b, Board of Directors; c, consultant; cf, cofounder; sp, speaker; st, stockholder. Sources: Fertig et al, 2017; Ho & Shapiro 2019; Young et al, 2023.


Antonella Tosti, MD
As of 2004: Department of Dermatology, University of Bologna. Moved to University of Miami in 2010 according to a Keeps profile.

  • Consultant and speaker for Merck (disclosed as ‘over 3 years ago’ in Fertig 2017; dates unknown)
  • Co-authors: Kaufman, Roberts, Shapiro, Whiting
  • Papers
    • Dr. Tosti was an author or co-author of 30 papers in which finasteride is mentioned (per PubMed search)
  • Engagements with industry*
    • Highlighted: Since mid-2020, Advisor to Thirty Madison, owner of telehealth company Keeps (Advisor profile), along with Dr. Jerry Shapiro. Co-author of finasteride trial report with Merck researchers; former consultant and speaker for Merck.
    • Other engagements with: Aclaris, Almirall, Bristol Myers Squibb, DS Laboratories, Eli Lilly, Incyte (c,pi), Kythera, Monat Global, Myovant, Nutrafol, Pfizer, Procter & Gamble.
  • Editorial roles: co-Editor-in-Chief of Skin Appendage Disorders.
  • Board position: National Alopecia Areata Foundation (Scientific Board Member)

* Key: a, author; c, consultant; cf, cofounder; sp, speaker; st, stockholder. Sources: Fertig et al, 2017; Gupta et al, 2019; Young et al, 2023.


David Whiting, MD (d. 2018)
Departments of Dermatology and Pediatrics, University of Texas, Southwestern Medical Center at Dallas, and the Baylor Hair Research and Treatment Center, Dallas (1999)
Dallas Associated Dermatologists (2003)


Sources of disclosures for Dr. Jerry Shapiro & Dr. Antonella Tosti: Fertig et al, 2017; Gupta et al, 2019; Ho & Shapiro 2019; Young et al, 2023.